Kiniksa Pharmaceuticals is a commercial-stage biopharmaceutical company developing and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. With deep expertise in immunology and inflammation, Kiniksa is advancing a growing portfolio of approved and investigational medicines, anchored by its lead product, ARCALYST®, the first and only FDA‑approved therapy for recurrent pericarditis. Grounded in rigorous science and bold innovation, the company fosters a highly collaborative, patient‑first culture led by accomplished life sciences leaders. At Kiniksa, talented individuals are trusted and empowered to make a real impact—shaping the future of medicine while improving the lives of patients who need it most. We are seeking a Clinical Development Lead (CDL) reporting to the Chief Medical Officer to oversee and drive strategic planning, execution, and oversight of clinical development programs across one or more assets. This role provides medical and scientific leadership to ensure the successful design, implementation, and interpretation of clinical studies, working cross-functionally to advance compounds from early development through regulatory approval. The ideal candidate is a strategic thinker with a hands-on understanding of the operational complexities of drug development and is eager to bring therapies to patients with a sense of urgency. This role is based in our Lexington, MA office and requires employees to be onsite five days per week.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Executive
Education Level
Ph.D. or professional degree